Reverse Lymphatic Mapping and Immediate Microsurgical Lymphatic Reconstruction Reduces Early Risk of Breast Cancer–Related Lymphedema
- 7 March 2022
- journal article
- research article
- Published by Wolters Kluwer Health in Plastic and Reconstructive Surgery
- Vol. 149 (5) , 1061-1069
Abstract
Background: Breast cancer–related lymphedema is a progressive disease that poses tremendous physical, psychosocial, and financial burden on patients. Immediate lymphaticovenular anastomosis at the time of axillary lymph node dissection is emerging as a potential therapeutic paradigm to decrease the incidence of breast cancer–related lymphedema in high-risk patients. Methods: Eighty-one consecutive patients underwent reverse lymphatic mapping and, when feasible, supermicrosurgical immediate lymphaticovenular anastomosis at the time of axillary lymph node dissection at a tertiary care cancer center. Patients were followed prospectively in a multidisciplinary lymphedema clinic (plastic surgery, certified lymphatic therapy, dietary, case management) at 3-month intervals with clinical examination, circumferential limb girth measurements, and bioimpedance spectroscopy. An institutional control cohort was assessed for the presence of objectively diagnosed and treated breast cancer–related lymphedema. Data were analyzed by a university statistician. Results: Seventy-eight patients met inclusion, and 66 underwent immediate lymphaticovenular anastomosis. Mean follow-up was 250 days. When compared to a retrospective control group, the rate of lymphedema in patients who underwent immediate lymphaticovenular anastomosis was significantly lower (6 percent versus 44 percent; p < 0.0001). Patients with 6-month follow-up treated with combined adjuvant radiation therapy and chemotherapy had significantly greater risk of developing breast cancer–related lymphedema (p = 0.04) compared to those without combined adjuvant therapy. Arborized anastomotic technique had a statistically shorter operative time than end-to-end anastomosis (p = 0.005). Conclusions: This series of consecutive patients demonstrate a 6 percent incidence of early-onset breast cancer–related lymphedema with immediate lymphaticovenular anastomosis and an increased risk in those undergoing combined adjuvant treatment. These early data represent an encouraging and substantial decrease of breast cancer–related lymphedema in high-risk patients. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, III.Keywords
This publication has 23 references indexed in Scilit:
- Single Institution Experience with Lymphatic Microsurgical Preventive Healing Approach (LYMPHA) for the Primary Prevention of LymphedemaAnnals of Surgical Oncology, 2015
- The “Octopus” Lymphaticovenular Anastomosis: Evolving Beyond the Standard Supermicrosurgical TechniqueJournal of Reconstructive Microsurgery, 2015
- Understanding the Three-Dimensional Anatomy of the Superficial Lymphatics of the LimbsPlastic and Reconstructive Surgery, 2014
- Lymphatic Microsurgical Preventing Healing Approach (LYMPHA) for primary surgical prevention of breast cancer-related lymphedema: Over 4 years follow-upMicrosurgery, 2014
- Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysisThe Lancet Oncology, 2013
- Psychosocial impact of lymphedema: a systematic review of literature from 2004 to 2011Psycho-Oncology, 2012
- Vascular Anomalies and LymphedemaPlastic and Reconstructive Surgery, 2010
- Feasibility of Axillary Reverse Mapping During Sentinel Lymph Node Biopsy in Breast Cancer PatientsAnnals of Surgical Oncology, 2009
- Lymphedema Microsurgical Preventive Healing Approach: A New Technique for Primary Prevention of Arm Lymphedema After MastectomyAnnals of Surgical Oncology, 2009
- A systematic review of common conservative therapies for arm lymphoedema secondary to breast cancer treatmentAnnals of Oncology, 2006